Welcome to Ray Kurzweil & Terry Grossman’s Health Products
Science is quickly developing the technologies needed to radically extend the quality human lifespan. Meanwhile, we need to stay healthy long enough to take advantage of these scientific breakthroughs.
  •  Products
  •  Entire Site


  • Support healthy CAC scores
  • Maintain cardiovascular health
  • Increase blood flow

Most heart attacks are caused by plaque in the coronary arteries. This waxy plaque builds up over time (a condition called atherosclerosis) and slows down blood flow. When inflammation and free radical damage occur, the plaque can rupture, resulting in blood clot formation. Parts of the heart cannot get oxygen and heart cells die (a heart attack).

The amount of atherosclerotic plaque in the heart arteries can be estimated by performing a Coronary Artery Calcium (CAC) Test. The higher the CAC score, the greater the amount of calcified plaque in the arteries. In one published study, NanobacTX was associated with CAC scores in a normal range.

What is NanobacTX?
It is a patented non-prescription compound nanobiotic that is used by healthcare professionals to support healthy CAC scores.

A 2004 study showed that this compound improved CAC scores in 57% of patients an average of 14%.4

NanobacTX is the only product ever shown to dissolve, eradicate and regress calcified arterial plaque and calcification deposits in blood vessels, organs and tissues.

How Does It Work?
Research for the past 15 years has established that infection by Nanobacteria (also referred to as CNPs or NPs) is the principal cause of the calcified plaque found in coronary artery disease and elsewhere in the body as atherosclerosis or pathological calcification.1,2,3

NanobacTX may help minimize deposits created by nanobacteria helping reduce the associated inflammation. In turn, this helps maintain healthy CAC scores, coronary artery blood flow and vascular flexibility.

Read more information below...

Supplement Facts
Serving Size: 8 capsules Amt/serving % Daily Value
Vitamin C 3,000 mg 5000%
Niacin (as Niacinamide) 50 mg 250%

Pyridoxine Hcl

82 mg 4100%
Folate 500 mcg 125%
Selenium 6.06 mcg 9%
Proprietary Blend 2435 mg *
Papain   *
Grapeseed Extract   *
Hawthorne Berry Powder   *
Coenzyme Q10   *
Trypsin   *
Bromelain   *
L-Ornithine Hcl   *
L-Lysine Hcl   *
L-Arginine Hcl   *
Edetate Disodium Dicalcium   *
* % Daily value not established

Other Ingredients: Cellulose, Mg Stearate & Silicon Dioxide.


  1. You can continue to take vitamin and mineral supplements. However, do not take any supplements after 12 Noon. The manufacturer’s research has shown that taking vitamin or mineral supplements at night could decrease the effectiveness of NanobacTX.
  2. We recommend a normal breakfast, a normal lunch and a very light evening meal.
  3. NanobacTX must be taken at bedtime.
  4. Store your bottle of NanobacTX in a cool and dry place. You may store it in the refrigerator, but never the freezer.
  5. For optimal absorption, NanobacTX Capsules must be swallowed whole and not emptied into beverages or foods.


Adult Dosage: Take 8 capsules every night AT BEDTIME with 6-16 ounces of clear apple juice or cool water. For ideal efficacy, take your capsules at least two hours after your evening meal. After taking the dose, lie down and go to sleep.

After an initial core therapy of 6-12 months of continuous full-strength use, a low–dose maintenance program is important. The Maintenance Dose is usually 1-2 capsules per night or as directed by your physician.

Our oral formula has improved patient tolerance & bioavailability compared to the original version. The unique patented capsules bypass the stomach’s acidity and allow for dissolution at ideal pH in the small bowel. This promotes the highest possible absorption, bioavailability and efficacy.

Side Effects: Adverse side effects are extremely rare, uncommon, minimal and generally limited to gas or loose stool that resolves within 7 days. Most people have no adverse symptoms at all. We would like to hear about your improvement!  Please share your updates and testimonials to us at: info@rayandterry.com

NanobacTX contains 240 vegetarian capsules per bottle. The capsules are a regulated delayed-release capsule that is acid-resistant to allow for optimal absorption by the small intestine.

A note on CAC testing: If you have a family history of coronary heart disease, Dr. Grossman recommends baseline screening at 40 for men and 45 for women. In the absence of such history, baseline screening is recommended at 45 for men and 50 for women.
(Note that there is radiation involved in this test and we do not recommend it for frequent use.)

This product is not a substitute for any Rx meds. This product is not intended for pregnant or nursing mothers, children under the age of 18, or persons with a known medical condition. If you have questions about the advisability of taking this product, consult your physician prior to use.

Store at room temperature. Avoid prolonged exposure to excessive heat or moisture.

NanobacTX is manufactured at an FDA-licensed pharmaceutical manufacturing facility according to strict Good Manufacturing Practices.

Supported by Science

Studies show that NanobacTX supports heart health and increases exercise ability. Dr. Terry Grossman, Dr. Matthew Budoff, Dr. Aubrey de Grey and Dr. Robert Atkins have served on the advisory board of this cutting edge formula.

> One study published in Pathophysiology concluded that the formula supports healthy CAC scores, suggesting plaque regression. Initial blood tests on all participants indicated the presence of nanobacteria.


Even though most heart attacks are caused by soft or vulnerable plaque, the amount of hard, calcified plaque in your coronary arteries is important because there is a direct correlation between the levels of hard and soft plaque in your arteries.

You can get an indirect measurement of how much soft plaque you have by measuring your hard plaque using a non-invasive imaging technique called a Coronary Computed Tomography “HeartScan” Score. The result is your coronary artery calcium score (CAC).

Optimally, your CAC score will be zero, meaning you have no detectable plaque. The higher the level, the greater your risk of heart attack. CAC scores can progress by as much as 40 percent per year without treatment.

You can learn more about the heart attack risk and hard and soft plaque in Chapter Two of Ray & Terry’s book, Transcend:Nine Steps to Living Well Forever, https://www.rayandterry.com/transcend/pdf/Transcend_Chapt2.pdf


10/11/11 - I am happy to know that there is a company...

"I am happy to know that there is a company and a group of well educated scientist and researchers specializing in longevity products and plans. This is for me, a new way to approach longevity at the right time of my life, and to start a new...

7/28/11 - You gentlemen are the future.

“You gentlemen are the future. Thanks for the inspiration.” -H.G.

7/14/10 - I want my family to benefit from what's in the book as well.

"I have followed the book closely. Not only is my blood chemistry back in order, but I am back to the weight I was as swimmer in college. Naturally, I want my family to be able to benefit from what's in the book as well. I so appreciate people ...

6/17/10 - The Process Continues

"Your last book helped me a lot, got me onto a better road, the process continues. Thanks Guys!!!" -Paul A.


  1. Puskas, L. G., L. Tiszlavicz, Zs Razga, L. Torday, T. Krenacs, J. G Papp. Detection of nanobacteria-like particles in human atherosclerotic plaques. Acta Biologica Hungarica56 (3-4): 233-245.
  2. Kajander, E O.Nanobacteria do exist and actively participate in the calcification of arterial plaque.Townsend Letter 234:80-82.
  3. Lopez-Brea M., R. Selgas. Nanobacteria as a cause of renal diseases and vascular calcifying pathology in renal patients (endovascular lithiasis).Enferm Infec. Microbiol. Cli. (Spanish).18(10):491-492.
  4. Maniscalco BS, Taylor KA. Calcification in coronary artery disease can be reversed by EDTA-tetracycline long-term chemotherapy. Pathophysiology. 2004 Oct;11(2):95-101.(For publishing purposes, NanobacTX is referred to as comET for generic purposes and not by actual trade name
  5. Mezo G, Ciftcioglu N, Kajander O, Maxfield WS. NanobacTX Pilot Study. Presented at: 1) International Nanobacteria Symposium, Kuopio, Finland, March 8, 2001. 2) GLCCM Spring Congress, Baltimore, MD, March 23, 2001.